Acalabrutinib in Patients With Relapsed/Refractory and Treatment naïve Deletion 17p CLL/SLL

Name: Acalabrutinib in Patients With Relapsed/Refractory and Treatment naïve Deletion 17p CLL/SLL
Published: 2015
License: Public Domain

Acerta Pharma BV · 2015

ClinicalTrials.gov · Datasets · License: Public Domain · 2015

Open Source ↗

leukemia lymphoma

chronic lymphocytic leukemia, small lymphocytic lymphoma, relapsed/refractory cll, btk, leukemia, lymphocytic, lymphoma, chronic lymphocytic leukemia (cll), small lymphocytic lymphoma (sll), acp-196, acalabrutinib, treatment naive cll

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 803591
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.